noted Rajiv Malik, president at Viatris. Innovation to end debate? One common defence of price increases across a broad range of pharmaceutical product has been that the profit generated is ...
AXIS ELSS Tax Saver Fund (G) 670.91 25,24,224 2.09 AXIS ELSS Tax Saver Fund (IDCW) 670.91 25,24,224 2.09 AXIS ELSS Tax Saver Fund - Direct (G) 670.91 25,24,224 2.09 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback